Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of autoimmune cholangitis.

× No keyword cloud information.

20 in total

Review 1. Primary biliary cirrhosis.

Authors: M M Kaplan
Journal: N Engl J Med Date: 1996-11-21 Impact factor: 91.245

2. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

Authors: P Sánchez-Pobre; G Castellano; F Colina; P Dominguez; S Rodriguez; F Canga; J A Herruzo
Journal: J Clin Gastroenterol Date: 1996-10 Impact factor: 3.062

3. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

Authors: R E Poupon; B Balkau; E Eschwège; R Poupon
Journal: N Engl J Med Date: 1991-05-30 Impact factor: 91.245

4. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.

Authors: U Leuschner; H Fischer; W Kurtz; S Güldütuna; K Hübner; A Hellstern; M Gatzen; M Leuschner
Journal: Gastroenterology Date: 1989-11 Impact factor: 22.682

5. [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

Authors: G Brunner; O Klinge
Journal: Dtsch Med Wochenschr Date: 1987-09-18 Impact factor: 0.628

6. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors: P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal: Gut Date: 1994-02 Impact factor: 23.059

7. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

Authors: E J Heathcote; K Cauch-Dudek; V Walker; R J Bailey; L M Blendis; C N Ghent; P Michieletti; G Y Minuk; S C Pappas; L J Scully
Journal: Hepatology Date: 1994-05 Impact factor: 17.425

8. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

Authors: R E Poupon; R Poupon; B Balkau
Journal: N Engl J Med Date: 1994-05-12 Impact factor: 91.245

9. Antimitochondrial antibody-negative primary biliary cirrhosis.

Authors: M A Lacerda; J Ludwig; E R Dickson; R A Jorgensen; K D Lindor
Journal: Am J Gastroenterol Date: 1995-02 Impact factor: 10.864

10. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases.

Authors: Z D Goodman; P R McNally; D R Davis; K G Ishak
Journal: Dig Dis Sci Date: 1995-06 Impact factor: 3.199